Everything you need to win InBios International — in one platform.
Who to reach, what to say, and why now on InBios International — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on InBios International — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
InBios Receives $16.5 Million Federal Award to Develop Test for Deadly Bacterial Infection
Dec 04, 2024•over 1 year ago
Contract Type
contract
SeattleBiotechnologyHealth Care
Description
InBios International, based in Seattle, received a $16.5 million project award from the U.S. Department of Health and Human Services to develop a test for melioidosis, a potentially deadly bacterial infection caused by Burkholderia pseudomallei. The company plans to utilize the funding to further develop its Active Melioidosis Detect Plus design and seek FDA clearance, with promising early testing results in several countries.
Company Information
Company
InBios International
Location
Seattle, Washington, United States
About
Seattle-based biotech InBios International, founded in 1996, specializes in making diagnostic tests for infectious diseases.
Predictive Intelligence
Strategic
ML-powered predictions for InBios International's next move
SeattleBiotechnologyHealth Care